ANK Cell Therapy

What is ANK Therapy?

ANK Therapy (Autologous Natural Killer cell therapy) is an advanced form of personalized immunotherapy. It uses your own immune cells—specifically Natural Killer (NK) cells, which are your body’s first line of defense—to fight cancer cells, abnormal cells, and inflammation. By
activating and expanding NK cells outside the body and reinfusing them, ANK therapy strengthens your immune system’s ability to protect your health and longevity.

Why ANK Therapy?

Patients often ask what makes ANK therapy different. Unlike chemotherapy or radiation, which can harm healthy cells, ANK therapy:

  • Uses your own immune cells for a tailored approach.
  • Targets cancer cells selectively without damaging normal tissue.
  • Is low-risk with fewer side effects.
  • Is minimally invasive—only requiring a blood draw and IV infusion, no surgery.

Potential Benefits

Cancer treatment support – targeting tumor cells directly.

Prevention of recurrence or metastasis for patients in remission.

Enhanced immunity and reduction of chronic inflammation.

Personalized therapy that adapts to your body’s own immune system.

Procedure

Preparations

Step 1.

Consultation

 Online or in-person (English, Japanese, or Chinese).

Step 2.

Blood Test

To check immune readiness and rule out infection.

Treatment

Step 3.

Blood Collection

About 40 ml of blood is drawn at the clinic.

clinic icon

Step 4.

Cell Culture

NK cells are expanded and activated in a sterile lab, safety-tested, and prepared for infusion.

Step 5.

Treatment

NK cells are reinfused via IV about 23 days after collection, typically once every 1–2 weeks for at least 3 treatments.

clinic icon

FAQs

Is it safe?

Most patients tolerate ANK therapy very well. Possible side effects may include:

  • Mild fever (37–38 °C), usually within a few hours of infusion.
  • Temporary redness or swelling at the injection site.
  • These effects typically resolve within 24 hours.
  • Patients with solid tumors seeking complementary therapy.
  • Those aiming to prevent recurrence or metastasis.
  • Individuals looking for gentler, personalized options compared to conventional cancer therapies.

Clinical studies of NK-related therapies have shown encouraging results, with response rates ranging from 24% to 39% across different cancer types, along with improvements in survival and quality of life.

Yes — ANK therapy is often combined with DC therapy (dendritic cell therapy). DC therapy “teaches” your immune system to recognize cancer cells, while NK cells attack and destroy them. Together, they provide a stronger, complementary defense.